About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

378040 studies
in
220 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 06/15/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 06/15/2021.

Computer Aided Detection of Polyps in the Colon

Clinicaltrials.gov identifier NCT03925337

Recruitment Status Recruiting

First Posted April 24, 2019

Last update posted June 22, 2020

Study Description

Brief summary:

The purpose of this study is to examine the role of an automatic polyp detection software (henceforth referred to as the research software) as a support system during colonoscopy; a procedure during which a physician uses a colonoscope or scope, to look inside a patient's rectum and colon. The scope is a flexible tube with a camera-to see the lining of the colon. The research software is used to aid in the detection of polyps (abnormal tissue growths in the wall of the colon and adenomas (pre-cancerous growths) during colonoscopy. The research software used in this study was programmed by a company in Shanghai, which develops artificial intelligence software for computer aided diagnostics. The research software was developed using a large repository (database or databases) of polyp images where expert colonoscopists outlined polyps and suspicious lesions. The software was subsequently developed and validated using several databases of images and video to operate in near real-time or within minutes of photographing the tissue. It is intended to point out polyps and suspicious lesions on a separate screen that stands behind the primary monitor during colonoscopy. It is not expected to change the colonoscopy procedure in any way, and the physician will make the final determination on whether or not to biopsy or remove any lesion in the colon wall. The research software will not record any video data during the colonoscopy procedure. In the future, this software may help gastroenterologists detect precancerous areas and decrease the incidence of colon cancer in the United States.

  • Condition or Disease:Polyp, Adenomatous
    Colo-rectal Cancer
  • Intervention/Treatment: Device: Computer Aided Diagnostic Software
  • Phase: N/A
Detailed Description

Length of Study - The duration of the study is expected to be 8-12 months. Enrollment of study patients will cease when approximately 250 patients have been enrolled. Study Design- Design will be a multi-center, prospective, unblinded randomized control trial. Patients referred for either screening or surveillance colonoscopy will be included. Equipment: Aside from standard of care scope used, a second computer monitor that will stand behind the standard monitor used during colonoscopy. Additionally , a computer system unit with an operating system. Standard Clinical Procedure Typically, intravenous sedation using a combination of benzodiazepine and narcotic medications (with or without propofol under the supervision of a trained anesthesiologist) are used for colonoscopy. Continuous pulse oximetry and blood pressure monitoring is used throughout the procedure. Supplemental oxygen is used as needed. Patients are usually placed in the left lateral decubitus position and the colonoscope is introduced into the rectum. The colonoscope is advanced under direct visualization until the cecum and appendiceal orifice is reached. The colonoscope is usually retroflexed within the rectum. The colonoscopist carefully inspects each segment of colon during advancement and then again on withdrawal of the colonoscope. Any suspicious lesions encountered during insertion or withdrawal are inspected by the colonoscopist and a final determination is made by the clinician on whether or not to remove a given lesion. Any lesion that is deemed suspicious or polypoid is removed by en-bloc polypectomy, piecemeal polypectomy, or may be referred for endoscopic mucosal resection (EMR) at a later date. After the procedure, patients recover in the post-procedural recovery room. After the procedure, results are discussed with the patient. The ability of colonoscopy to detect lesions is discussed with the patient as well as the fact that a small percentage of polyps and other lesions may be missed during the test. Study Procedure Patients will receive a colonoscopy with a gastroenterologist. During the standard clinical procedural protocol and for the study period, colonoscopists will have the benefit of a second monitor that will project the polyp detection algorithm in real-time over the video output of the colonoscopy. The algorithm will detect suspicious, polyp-like lesions within the lumen of the colon, and during the procedure a research assistant will view the second monitor at all times and record a time stamp for any potential polyps on an intra-procedural data collection sheet. Data Collection Variables collected and measured will include colonoscopist(s) performing the procedure, number of adenomas noted per procedure, adenoma detection rate for a given colonoscopist, number of polyps detected per procedure, polyp detection rate (the proportion of colonoscopic examinations performed that detect one or more polyps), cecal intubation rate, time needed to reach the cecum, time needed to withdraw colonoscope both when polyps are identified (and thus need to be removed) and on normal colonoscopy, level of sedation, and complications: Acute if within 48 hours of procedure & delayed if within 3-30 days after procedure. Data Analysis - Normally distributed continuous variables will be summarized using means and standard deviations while non-normally distributed continuous variables will be summarized using medians and ranges.

Study Design
  • Study Type: Interventional
  • Estimated Enrollment: 200 participants
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Intervention Model Description: In this study, the colonoscopist will carefully inspect segments of colon during advancement and then again on withdrawal of the colonoscope. Those who qualify will be randomized into two arms, as detailed in the bullets below: scope Insertion will be the same for both arms, without the aid of the research software. Below are two groups that qualifying subjects will be randomized into: Group of patients in Arm-1- recruited patients will receive Standard Colonoscopy followed by AI-Assisted Combined Colonoscopy Group of patients in Arm-2- recruited patients will received AI-Assisted Combined Colonoscopy followed by Standard Colonoscopy
  • Masking: None (Open Label) ()
  • Primary Purpose: Diagnostic
  • Official Title: Computer Aided Detection of Polyps in the Colon
  • Actual Study Start Date: May 2019
  • Estimated Primary Completion Date: December 2020
  • Estimated Study Completion Date: December 2020
Arms and interventions
Arm Intervention/treatment
Experimental: Arm-1 Standard Colonoscopy/AI-Assisted Combined Colonoscopy
Normal scope insertion and withdrawal first, followed by a second withdrawal with the research software running on a separate screen to catch any additional polyps missed during the first withdrawal.
Device: Computer Aided Diagnostic Software
The research software is deep learning algorithm used to aid in the detection of polyps (abnormal tissue growths in the wall of the colon and adenomas (pre-cancerous growths) during colonoscopy. In its current form, the automatic polyp detection system is installed on a computer system unit that utilizes an an operating system.
Experimental: Arm-2 AI-Assisted Combined Colonoscopy/Standard Colonoscopy
Normal scope insertion but first withdrawal with the research software running on a separate screen, followed by a second withdrawal without the research software running.
Device: Computer Aided Diagnostic Software
The research software is deep learning algorithm used to aid in the detection of polyps (abnormal tissue growths in the wall of the colon and adenomas (pre-cancerous growths) during colonoscopy. In its current form, the automatic polyp detection system is installed on a computer system unit that utilizes an an operating system.
Outcome Measures
  • Primary Outcome Measures: 1. Adenoma Miss Rate (AMR) [ Time Frame: One Hour ]
    Adenoma Miss Rate (AMR), to determine if the combination technique identifies more adenomas compared to the standard technique. AMR will be calculated as the number of adenomas detected on the second pass or portion in either group divided by the total number of adenomas detected during both passes
  • Secondary Outcome Measures: 1. Total procedure time determination [ Time Frame: During length of procedure ]
    The entire duration of the procedure.
  • 2. Polyp Miss Rate (PMR) [ Time Frame: One Hour ]
    To determine the accuracy of the polyp detection software by determining if the combination technique identifies more polyps compared to the standard technique: Per-patient true positive, false positive and false negative will be recorded. True positives will be defined as lesions that are detected for >2 seconds by the research software and are deemed to be consistent in appearance with a polyp by the endoscopist. False positives will be defined as lesions that are detected for > 2 seconds by the research software but are ultimately deemed by the endoscopist to have a gross appearance not consistent with polyp. False negatives will be defined as lesions that are not detected, or detected for <2 seconds by the research software, but are deemed by the endoscopist to be consistent with polyp
  • 3. Amplified adenoma detection rate [ Time Frame: 6 months ]
    To determine if the combination of an automated polyp detection software and standard colonoscopy will have a higher detection rate of adenomas
  • 4. Advanced adenoma miss rate determination [ Time Frame: 6 months ]
    Advanced adenoma miss rate will be calculated as the number of advanced adenomas [adenoma that is ≥ 10 mm in size] detected on the second pass or portion in either group divided by the total number of advanced adenomas detected during both passes.
  • 5. Colonoscope segmental withdrawal time determination [ Time Frame: 6-10 minutes ]
    The time it takes to withdraw the colonoscope from the end of the colon back to the rectum. This is the time that your gastroenterologist will be looking for polyps most.
  • 6. Rate of adverse event determination [ Time Frame: 6 months ]
    We will be monitoring the rate of adverse events related to the procedure for the duration of the study.
Eligibility Criteria
  • Ages Eligible for Study: 22 Years and older (Adult, Older Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: No
Criteria

Inclusion Criteria:

- Patients age: ≥ 22 years

- Patients presenting for routine colonoscopy for screening and/or surveillance
purposes.

- Willingness to undergo two withdrawals with and without the use of computer-aided
software while undergoing conventional colonoscopy with sedation

- Ability to provide written, informed consent and understand the responsibilities of
trial participation

Exclusion Criteria:

- Minors aged 2 cm concerning for invasive cancer on
endoscopy

- Patients referred for endoscopic mucosal resection (EMR), which is a procedure to
remove early-stage cancer and precancerous growths from the lining of the digestive
tract.

Contacts and Locations
Contacts

Contact: Tyler M. Berzin, MD [617] 632-8623 tberzin@bidmc.harvard.edu

Contact: Jeremy R Glissen Brown, MD jglissen@bidmc.harvard.edu

Locations

United States, Illinois
University of Chicago
Chicago

United States, Massachusetts
Beth Israel Deaconess Medical Center
Boston

United States, New York
NYU Langone
New York

United States, Texas
Baylor College of Medicine
Houston

Sponsors and Collaborators

Beth Israel Deaconess Medical Center

Investigators

Principal Investigator: Tyler M Berzin, MD Beth Israel Deaconess Medical Center

More Information